Literature DB >> 21331072

MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study.

M Pigazzi, R Masetti, S Bresolin, A Beghin, A Di Meglio, S Gelain, L Trentin, E Baron, M Giordan, A Zangrando, B Buldini, A Leszl, M C Putti, C Rizzari, F Locatelli, A Pession, G Te Kronnie, G Basso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21331072     DOI： 10.1038/leu.2010.316

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  17 in total

1.  Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group.

Authors:  E Manara; G Basso; M Zampini; B Buldini; C Tregnago; R Rondelli; R Masetti; V Bisio; M Frison; K Polato; G Cazzaniga; G Menna; F Fagioli; P Merli; A Biondi; A Pession; F Locatelli; M Pigazzi
Journal:  Leukemia       Date:  2016-06-28       Impact factor: 11.528

2.  LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19.

Authors:  Hetty H Helsmoortel; Barbara De Moerloose; Tim Pieters; Farzaneh Ghazavi; Silvia Bresolin; Hélène Cavé; Andrica de Vries; Valerie de Haas; Christian Flotho; Veerle Labarque; Charlotte Niemeyer; Pascale De Paepe; Nadine Van Roy; Jan Stary; Marry M van den Heuvel-Eibrink; Yves Benoit; Johannes Schulte; Steven Goossens; Geert Berx; Jody J Haigh; Frank Speleman; Pieter Van Vlierberghe; Tim Lammens
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

3.  Hes1 suppresses acute myeloid leukemia development through FLT3 repression.

Authors:  T Kato; M Sakata-Yanagimoto; H Nishikii; M Ueno; Y Miyake; Y Yokoyama; Y Asabe; Y Kamada; H Muto; N Obara; K Suzukawa; Y Hasegawa; I Kitabayashi; K Uchida; A Hirao; H Yagita; R Kageyama; S Chiba
Journal:  Leukemia       Date:  2014-09-19       Impact factor: 11.528

4.  Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.

Authors:  Claudia Tregnago; Ambra Da Ros; Elena Porcù; Maddalena Benetton; Manuela Simonato; Luca Simula; Giulia Borella; Katia Polato; Sonia Minuzzo; Giulia Borile; Paola Cogo; Silvia Campello; Alessandro Massi; Romeo Romagnoli; Barbara Buldini; Franco Locatelli; Martina Pigazzi
Journal:  Blood Adv       Date:  2020-09-22

5.  Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.

Authors:  Aniruddha J Deshpande; Liying Chen; Maurizio Fazio; Amit U Sinha; Kathrin M Bernt; Deepti Banka; Stuart Dias; Jenny Chang; Edward J Olhava; Scott R Daigle; Victoria M Richon; Roy M Pollock; Scott A Armstrong
Journal:  Blood       Date:  2013-01-29       Impact factor: 22.113

6.  Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.

Authors:  Jasmijn D E de Rooij; Riccardo Masetti; Marry M van den Heuvel-Eibrink; Jean-Michel Cayuela; Jan Trka; Dirk Reinhardt; Mareike Rasche; Edwin Sonneveld; Todd A Alonzo; Maarten Fornerod; Martin Zimmermann; Martina Pigazzi; Rob Pieters; Soheil Meshinchi; C Michel Zwaan; Franco Locatelli
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

7.  Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach.

Authors:  Barbara Depreter; Barbara De Moerloose; Karl Vandepoele; Anne Uyttebroeck; An Van Damme; Eva Terras; Barbara Denys; Laurence Dedeken; Marie-Françoise Dresse; Jutte Van der Werff Ten Bosch; Mattias Hofmans; Jan Philippé; Tim Lammens
Journal:  Pediatr Res       Date:  2020-10-17       Impact factor: 3.756

8.  Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Authors:  Erica Ballabio; Thomas A Milne
Journal:  Cancers (Basel)       Date:  2012-09-10       Impact factor: 6.639

9.  Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.

Authors:  Lili Chen; Yuqing Sun; Jingya Wang; Hui Jiang; Andrew G Muntean
Journal:  Oncotarget       Date:  2016-05-03

10.  Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.

Authors:  Andrew P Voigt; Lisa Eidenschink Brodersen; Todd A Alonzo; Robert B Gerbing; Andrew J Menssen; Elisabeth R Wilson; Samir Kahwash; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Denise A Wells; Michael R Loken
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.